Harfst & Associates, Inc. West Pharmaceutical Services Inc Transaction History

Harfst & Associates, Inc.

$423 Million
Q1 2025

A detailed history of Harfst & Associates, Inc. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Harfst & Associates, Inc. holds 3,732 shares of WST stock, worth $805,440. This represents 0.2% of its overall portfolio holdings.

Number of Shares

3,732

Previous 7,640 51.15%

Holding current value

$805,440

Previous $2.5 Million 66.63%

% of portfolio

0.2%

Previous 0.53%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$199.11 - $347.87 $778,121 - $1.36 Million	-3,908 Reduced 51.15%	3,732 $835,000
Q4 2024 Feb 04, 2025	BUY	$285.69 - $344.0 $44,567 - $53,664	156 Added 2.08%	7,640 $2.5 Million
Q3 2024 Oct 18, 2024	BUY	$277.16 - $333.3 $152,715 - $183,648	551 Added 7.95%	7,484 $2.25 Million
Q2 2024 Aug 01, 2024	BUY	$314.68 - $395.94 $33,356 - $41,969	106 Added 1.55%	6,933 $2.28 Million
Q1 2024 Apr 22, 2024	SELL	$338.27 - $413.0 $51,755 - $63,189	-153 Reduced 2.19%	6,827 $2.7 Million
Q4 2023 Feb 07, 2024	SELL	$318.29 - $392.21 $52,517 - $64,714	-165 Reduced 2.31%	6,980 $2.46 Million
Q3 2023 Nov 07, 2023	SELL	$354.9 - $412.41 $4,258 - $4,948	-12 Reduced 0.17%	7,145 $2.68 Million
Q2 2023 Aug 07, 2023	BUY	$334.63 - $382.47 $21,750 - $24,860	65 Added 0.92%	7,157 $2.74 Million
Q1 2023 May 10, 2023	SELL	$232.5 - $346.47 $1,627 - $2,425	-7 Reduced 0.1%	7,092 $2.46 Million
Q4 2022 Feb 13, 2023	BUY	$209.34 - $261.61 $54,428 - $68,018	260 Added 3.8%	7,099 $1.67 Million
Q3 2022 Oct 27, 2022	BUY	$246.08 - $343.65 $141,988 - $198,286	577 Added 9.21%	6,839 $1.68 Million
Q2 2022 Jul 28, 2022	SELL	$280.61 - $420.45 $71,555 - $107,214	-255 Reduced 3.91%	6,262 $1.89 Million
Q1 2022 Apr 28, 2022	BUY	$357.49 - $445.92 $192,687 - $240,350	539 Added 9.02%	6,517 $2.68 Million
Q4 2021 Feb 07, 2022	BUY	$402.25 - $471.34 $121,479 - $142,344	302 Added 5.32%	5,978 $2.8 Million
Q3 2021 Oct 28, 2021	SELL	$363.01 - $468.47 $108,539 - $140,072	-299 Reduced 5.0%	5,676 $2.41 Million
Q2 2021 Aug 11, 2021	SELL	$284.77 - $363.2 $102,801 - $131,115	-361 Reduced 5.7%	5,975 $2.15 Million
Q1 2021 May 10, 2021	BUY	$257.29 - $307.53 $281,732 - $336,745	1,095 Added 20.89%	6,336 $1.79 Million
Q4 2020 Jan 25, 2021	BUY	$261.16 - $301.66 $98,196 - $113,424	376 Added 7.73%	5,241 $1.48 Million
Q3 2020 Nov 04, 2020	SELL	$224.99 - $288.02 $253,788 - $324,886	-1,128 Reduced 18.82%	4,865 $1.34 Million
Q2 2020 Aug 07, 2020	SELL	$149.8 - $227.17 $51,830 - $78,600	-346 Reduced 5.46%	5,993 $1.36 Million
Q1 2020 May 05, 2020	BUY	$128.96 - $174.76 $27,210 - $36,874	211 Added 3.44%	6,339 $965,000
Q4 2019 Feb 14, 2020	BUY	$137.6 - $151.21 $12,796 - $14,062	93 Added 1.54%	6,128 $921,000
Q3 2019 Nov 14, 2019	BUY	$121.41 - $150.02 $5,827 - $7,200	48 Added 0.8%	6,035 $855,000
Q2 2019 Aug 14, 2019	BUY	$111.27 - $125.15 $37,943 - $42,676	341 Added 6.04%	5,987 $749,000
Q1 2019 May 01, 2019	BUY	$94.53 - $110.2 $83,375 - $97,196	882 Added 18.51%	5,646 $622,000
Q4 2018 Feb 06, 2019	BUY	$93.0 - $123.98 $37,479 - $49,963	403 Added 9.24%	4,764 $467,000
Q3 2018 Oct 31, 2018	BUY	$98.01 - $123.47 $15,093 - $19,014	154 Added 3.66%	4,361 $538,000
Q2 2018 Aug 10, 2018	BUY	$83.32 - $101.88 $6,248 - $7,641	75 Added 1.82%	4,207 $417,000
Q1 2018 May 07, 2018	BUY	$85.56 - $102.4 $16,513 - $19,763	193 Added 4.9%	4,132 $364,000
Q4 2017 Feb 09, 2018	BUY	$91.65 - $101.65 $12,097 - $13,417	132 Added 3.47%	3,939 $388,000
Q2 2017 Aug 11, 2017	BUY	N/A	3,807	3,807 $359,000

Others Institutions Holding WST

# of Institutions

803

Shares Held

66.2M

Call Options Held

415K

Put Options Held

275K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $16B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.

Account

Harfst & Associates, Inc. West Pharmaceutical Services Inc Transaction History